Medical Adhesive & Sealant Manufacturing in European Union: Market Size, Businesses & Forecast 2026

The medical adhesive and sealant manufacturing industry in the European Union provides highly specialized bonding, sealing, and wound-closure materials crucial for modern surgical procedures, medical devices, and advanced wound care. According to the European Association for the Adhesive and Sealant Industry (FEICA), the broader European adhesive and sealant sector contributed over €20.7 billion to the European economy in 2025. Driven by an aging population and a strong shift toward minimally invasive surgical procedures, manufacturers are heavily investing in research and development, which typically consumes 5% to 6% of sales turnover to ensure high biocompatibility and strict safety stand

Industry snapshot

Key public data points

Historical & forecast

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

What does the Medical Adhesive & Sealant Manufacturing in European Union industry cover?

This industry involves the development, formulation, and manufacturing of specialty chemical substances designed to bond organic tissue, seal surgical wounds, or assemble medical devices and equipment. These products can be broadly classified into synthetic formulations like cyanoacrylates, silicones, and acrylics, as well as natural formulations including fibrin, collagen, and albumin-based sealants. While the official European classification NACE Rev. 2 groups these operations under NACE Code 20.52 ('Manufacture of glues'), medical-grade adhesives represent a high-value-added segment that must meet stringent biocompatibility and sterilization standards.

• •Encompasses both internal application (tissue adhesives, hemostatic sealants) and external application (wound care, medical tapes, wearable biosensors).
• •Differs from industrial adhesives due to strict requirements for non-toxicity, minimal cell inflammatory response, and controlled biodegradability.
• •Production requires cleanroom manufacturing facilities operating under ISO 13485 quality management system standards.

Who operates in the industry and how is it structured?

The European adhesive and sealant market structure is highly specialized and research-intensive, with a substantial portion of the industry consisting of Small and Medium-sized Enterprises (SMEs). FEICA notes that approximately 85% of adhesive and sealant companies in Europe operate as SMEs, though medical-grade manufacturing is dominated by large, resource-rich multinationals capable of funding prolonged clinical evaluation and regulatory processes. Operators are typically grouped into bulk chemical formulators, specialized medical device converters, and clinical-grade pharmaceutical manufacturers.

• •In 2025, European adhesive and sealant companies spent approximately €580 million on research and innovation.
• •SMEs drive niche medical innovations in wearable device adhesion, while multinationals handle high-volume clinical supply chains.
• •Production is concentrated in key industrial clusters within Germany, France, Italy, and Belgium, aligning with the EU's chemical manufacturing hub.

What drives demand in the industry?

The primary demand drivers for medical adhesives and sealants in the EU include a growing volume of surgical procedures associated with an aging demographic and a systemic medical shift towards minimally invasive procedures. Adhesives are increasingly preferred over traditional mechanical closures like staples or sutures due to their ability to provide instant, fluid-tight sealing, lower infection rates, and improved cosmetic outcomes. Furthermore, the rapid growth of wearable healthcare monitors and advanced biosensors is creating a strong need for skin-friendly, long-wear external adhesives.

• •Surgeons increasingly adopt bio-compatible sealants for internal tissue reconstruction to minimize postoperative fluid leakage.
• •Increasing global prevalence of chronic skin conditions and diabetic ulcers drives demand for advanced, moisture-permeable wound dressings.
• •Rapid growth of consumer and medical wearables requires specialty, low-irritation pressure-sensitive adhesives (PSAs).

Who are the notable companies in the industry?

The competitive landscape features a mix of global chemical conglomerates and specialized medical device suppliers with deeply integrated European manufacturing footprints. Major participants focus on continuous material innovation to comply with safety standards while maintaining high mechanical strength. Notable public and established multinational operators in this space include Henkel AG & Co. KGaA, Sika AG, Bostik (a subsidiary of Arkema), Avery Dennison Corporation, and UPM Raflatac.

• •Henkel AG & Co. KGaA, headquartered in Germany, is a leading provider of medical-grade cyanoacrylates and acrylics under its Loctite brand.
• •Sika AG, which recorded net sales of CHF 11,201.3 million in 2025, produces advanced polymer sealants across the EMEA region.
• •Avery Dennison Corporation operates Avery Dennison Medical, supplying custom skin-contact adhesives, wearable device tapes, and medical-grade films.
• •Bostik, the specialty adhesives business of France's Arkema, develops advanced smart bonding solutions for hygienic and medical disposables.

What are the recent trends and outlook?

A prominent trend in the European market is the aggressive pursuit of bio-based and solvent-free raw materials to replace fossil-based formulations, aligning with the EU's green mandates. High regulatory pressure to reduce volatile organic compounds (VOCs) and chemical hazards has accelerated the development of solid hot melt technologies and natural resins. While raw material supply chain fluctuations have impacted production costs across Europe, the medical adhesive segment is expected to see a highly stable outlook due to its non-discretionary nature and high profit margins.

• •Solid hot-melt technology is expanding rapidly as medical manufacturers seek solvent-free formulations with low VOC emissions.
• •Recent raw material shortfalls, such as vinyl acetate monomer (VAM) deficits exceeding 500,000 tonnes in Europe, have historically pressured margins.
• •The European Commission's Clean Industrial Deal, introduced to bolster competitiveness, is expected to support future industrial innovation and green transitions.

How is the industry regulated?

Medical adhesives and sealants marketed in the EU are subject to some of the strictest regulatory frameworks globally, governed primarily by the EU Medical Device Regulation (MDR) and the REACH Chemical Regulation. Under the MDR, products must undergo rigorous biocompatibility assessments (including ISO 10993 testing) to ensure they are non-toxic, non-sensitizing, and safe for bodily contact. Additionally, chemical ingredients are thoroughly evaluated under the REACH framework to eliminate substances of very high concern (SVHC) from medical supply chains.

• •Manufacturers must secure CE-marking and maintain rigorous clinical technical documentation to sell medical adhesives in the EU.
• •The European Chemicals Agency (ECHA) continuously updates REACH, requiring manufacturers to phase out hazardous plasticizers and solvents.
• •Pharmaceutical labeling and adhesive systems must also align with standards such as ISO 21976 for tamper verification in packaging.

Government, statistical and trade sources used for this Claight analysis.

• FEICA Association of the European Adhesive and Sealant Industry (2025 Publications) ·
• Sika AG Annual Report 2025 ·
• Eurostat Trade and Production of Chemicals and Related Products 2024 ·
• European Chemicals Agency (ECHA) REACH Regulations Guideline 2025 ·
• European Commission Medical Device Regulation (MDR) Framework